Study identifies PTX-3 as potential marker for long COVID and tissue damage
A research team working at MedUni Vienna has demonstrated that a specific component of the immune system (PTX-3)…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
electronRx to launch pDx app for remote chronic respiratory disease management
electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
UCL launches landmark trial of Alzheimer’s blood test
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test,…
SLIT2 protein levels in the eye and blood linked to cognitive function
Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials
Some of the populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials-and a…